Skip to main content
Equibles

RAFFA WEALTH MANAGEMENT, LLC

Position in ADIL — Adial Pharmaceuticals, Inc.

CIK 1631073 WASHINGTON, DC
Back to ADIL Full portfolio

Position in ADIL

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$212
+$64 QoQ
Shares Held
83
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 4 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADIL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RAFFA WEALTH MANAGEMENT, LLC holds $112,928 across 35 Biotechnology names. ADIL ranks #26 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 66 $32,784
2 REGN
Regeneron Pharmaceuticals, Inc.
 25 $15,588
3 RVMD
Revolution Medicines, Inc.
 46 $8,614
4 PTGX
Protagonist Therapeutics, Inc
 60 $7,354
5 ROIV
Roivant Sciences Ltd.
 191 $6,759
6 ALNY
Alnylam Pharmaceuticals, Inc.
 21 $6,321
7 ARGX
Argenx SE
 5 $4,638
8 MRNA
Moderna, Inc.
 63 $4,411

All Filings in ADIL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $212 83
2026-03-31 $148 83
2025-12-31 $11,511 2,093
2025-09-30 $18,313 2,093
2025-06-30 $15,697 2,093
2025-03-31 $32,964 2,093
2024-12-31 $52,848 2,093
2024-09-30 $52,325 2,093
2024-06-30 $60,173 2,093
2024-03-31 $69,592 2,093
2023-12-31 $97,324 2,093
2023-09-30 $145,463 2,093
2023-06-30 $6,868,837 52,334
2023-03-31 $11,448,062 52,334
2022-12-31 $7,195,925 52,334
2022-09-30 $11,448,062 52,334
2022-06-30 $43,829,725 52,334
2022-03-31 $52,567,781 41,845
2021-12-31 $70,613,437 41,845
2021-09-30 $112,196,906 41,845
2021-06-30 $66,690,468 41,845
2021-03-31 $63,290,562 41,845
2020-12-31 $44,460,312 41,845
2020-09-30 $58,321,468 41,845
2020-06-30 $36,352,843 41,845
2020-03-31 $33,999,062 41,845

Report a Problem

Category
Description
Email (optional, for follow-up)